Drug news
NICE now recommends Stelara for treatment of Psoriatic Arthritis- Janssen Cilag
The National Institute for Health and Care Excellence issued guidance, reversing an earlier negative decision, to now endorse Stelara (ustekinumab) from Janssen Cilag as a cost effective option for treatment of Psoriatic Arthritis alone or in combination with methotrexate when TNF alpha inhibitors are contraindicated or where the patient has had treatment with one or more TNF alpha Inhibitors. A patient access scheme has been agreed.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.